Trials / Completed
CompletedNCT05987904
Feasibility Study for Instant Cardiac Diagnostic and Post-operative Risk Assessment with the LynxPatch Device
MDR - Feasibility Study for Instant Cardiac Diagnostic and Post-operative Risk
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,097 (actual)
- Sponsor
- Lynx Health Science GmbH · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In this clinical study the investigators will evaluate if it is feasible to pre-operatively identify low-risk patients, and to identify patients with cardiac pathologies with the LynxPatch.
Detailed description
The LynxPatch is a non-invasive, wireless device for cardiac diagnosis. The aim of this study is to compare the LynxPatch predictions with the echocardiographic diagnoses of cardiac pathologies and to evaluate its perioperative risk predictions in non-cardiac surgeries. The study population includes 1100 patients that scheduled for an echocardiographic assessment or for a non-cardiac surgery. The LynxPatch measurement procedure has a duration of about 30 minutes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | LynxPatch | Measurements with the LynxPatch device are conducted. |
Timeline
- Start date
- 2023-10-02
- Primary completion
- 2024-06-20
- Completion
- 2024-06-20
- First posted
- 2023-08-14
- Last updated
- 2024-10-30
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT05987904. Inclusion in this directory is not an endorsement.